9 terminated. 9 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Terminated 9 |
| Phase 3 | 1 | Terminated 1 |
Follow Hemangioma: new trials by email Literature Review of Hemangioma trials Research Report on Hemangioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation Propranolol, DNA and RNA Analysis - Cerebral Cavernous Malformations | Phase 2 | Terminated | St. Joseph's Hospital and Medical Center, Phoenix | 4 | 2018-01-24 | 2024-04-19 |
| A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors Vincristine, Sirolimus - Kaposiform Hemangioendothelioma (KHE), Kasabach-Merritt Syndrome | Phase 2 | Terminated | Boston Children's Hospital | 4 | 2017-06-14 | 2023-09-21 |
| TKI 258 in Von Hippel-Lindau Syndrome (VHL) Dovitinib - Von Hippel-Lindau Syndrome | Phase 2 | Terminated | M.D. Anderson Cancer Center | 6 | 2012-11-01 | 2017-02-13 |
| Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH) Prednisolone (Corticosteroid), Propranolol, Placebo - Hemangioma | Phase 2 | Terminated | Seattle Children's Hospital | 9 | 2010-02-01 | 2018-10-04 |
| Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas propranolol, Prednisolone - Hemangioma of Infancy | Phase 2 | Terminated | Nancy Bauman | 19 | 2009-07-01 | 2016-02-24 |
| Propranolol in Capillary Hemangiomas propranolol treatment, placebo treatment - Hemangioma, Capillary | Phase 2 / Phase 3 | Terminated | University Hospital, Bordeaux | 14 | 2008-10-01 | 2026-06-01 |
| The Effects of Aldara as an Adjunct to Laser Treatment Imiquimod, non-medicated petroleum cream - Port Wine Stains | Phase 2 | Terminated | Henry Vasconez | 7 | 2008-10-01 | 2018-03-22 |
| Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas Vincristine, Prednisone - Hemangioma | Phase 2 | Terminated | Medical College of Wisconsin | 8 | 2007-11-01 | 2013-06-11 |
| Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow SU011248 - Von Hippel-Lindau Syndrome, Renal Cell Carcinoma | Phase 2 | Terminated | M.D. Anderson Cancer Center | 15 | 2006-05-01 | 2024-06-27 |
Hemangioblastoma (2) · Hemangioma, Capillary (2) · von Hippel-Lindau Disease (2) · Carcinoma, Renal Cell (1) · Central Nervous System Neoplasms (1) · Cysts (1) · Hemangioendothelioma (1) · Hemangioma, Cavernous, Central Nervous System (1) · Kaposiform Hemangioendothelioma (1) · Kasabach-Merritt Syndrome (1) · Neoplasms (1) · Pigmentation Disorders (1) · Tufted angioma (1) · Vascular Malformations (1)
Neoplasms by Histologic Type (9) · Neoplasms, Vascular Tissue (9) · Neoplasms (8) · Cardiovascular Diseases (4) · Congenital Abnormalities (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Nervous System Diseases (3) · Vascular Diseases (3) · Abnormalities, Multiple (2) · Angiomatosis (2) · Cardiovascular Abnormalities (2) · Ciliopathies (2) · Genetic Diseases, Inborn (2) · Hemangioma, Capillary (2)
Propranolol (3) · Prednisolone (2) · Solutions (2) · Vincristine (2) · 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one (1) · Adrenal Cortex Hormones (1) · DNA (1) · Imiquimod (1) · Methylprednisolone (1) · Prednisone (1) · Sirolimus (1) · Sunitinib (1) · prednisolone phosphate (1)
M.D. Anderson Cancer Center (2) · Boston Children's Hospital (1) · Henry Vasconez (1) · Medical College of Wisconsin (1) · Nancy Bauman (1) · Seattle Children's Hospital (1) · St. Joseph's Hospital and Medical Center, Phoenix (1) · University Hospital, Bordeaux (1)
United States (8) · France (1)
Eric Jonasch, MD (2) · Beth Drolet, MD (1) · Denise Adams, MD (1) · Henry C. Vasconez, MD (1) · Jonathan A Perkins, DO (1) · Joseph Zabramski, MD (1) · Michael Kelly, MD, PhD (1) · Nancy M Bauman, MD (1) · Nicholas Moore, Professor (1)
PMID 22105611, PMID 23301692, PMID 24347141, PMID 24526257, PMID 26813215, PMID 29571951, PMID 34783716
2008 (1)